3Gupta V, Rawat of aerosolized pro A, hhsan staglandin F. Feasibility study E1 microspheres a noninvasive therapy for pulmonary arter as ial hypertension[J].J Pharm Sei, 2010,99(4):1774-1789.
4Infusion Nurses Society standards of practice[J]. Infus 92 Infusion Nurs, 2006 nursing 29(1): 1-92.
5Matsuo using the patients disease J, 2010, 74: H, Shigematsu H. Patient-based outcomes walking impairment questionnaire for with peripheral arterial occlusive treated with Ljpo-PGEI[J]. Cire 365-370.
6Giri TK, Choudhary C, hjazuddin, Alexander A, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for delivery[J]. Saudi Pharmaceutica controlled 1 Society,2013, 21 (2): 125-141.
9Zec. study Dragana Milutinovic, Dragana Risk factor of nurses' for phlebitis: a Simin, Davor questionnaire perception. Rev. Latino-Am Enfermagem 2015, 23(4): 677-84.
10Valbousquet Schneider L lrl, Duron S Evaluation of PICC complications inpatients with bone infection intravenous antibiotics therapy[J] 2015 ,16(4):299-308 in orthopedic for long-term Vasc Access.
